In this interview, Gerald V. Naccarelli and Stephen D. Wiviott discuss the DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events–Thrombolysis in Myocardial Infarction 58) trial.
See All 162 Episodes of "ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research"